Should You Buy UnitedHealth Group Inc (UNH) in Health Care Plans Industry?

Wednesday, June 17, 2020 3:22 PM | InvestorsObserver Analysts

UnitedHealth Group Inc (UNH) is near the top in its industry group according to InvestorsObserver. UNH gets an overall rating of 82. That means it scores higher than 82 percent of stocks. UnitedHealth Group Inc gets a 89 rank in the Health Care Plans industry. Health Care Plans is number 1 out of 148 industries.

Overall Score - 82
UNH has an Overall Score of 82. Find out what this means to you and get the rest of the rankings on UNH!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 82 would rank higher than 82 percent of all stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With UnitedHealth Group Inc Stock Today?

UnitedHealth Group Inc (UNH) stock is up 0.31% while the S&P 500 is down -0.01% as of 3:10 PM on Wednesday, Jun 17. UNH is higher by $0.91 from the previous closing price of $292.82 on volume of 1,639,655 shares. Over the past year the S&P 500 has gained 7.08% while UNH is higher by 19.55%. UNH earned $14.28 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 20.57.

To screen for more stocks like UNH click here.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Should You Buy Pacific Biosciences of California Inc (PACB) Stock on Monday?

Is Fennec Pharmaceuticals Inc (FENC) Stock About to Get Hot Monday?

Do Traders View Akers Biosciences Inc (AKER) Stock's Current Trend Positively?

Will T2 Biosystems Inc (TTOO) Beat the Rest of the Stocks in the Healthcare Sector?

Is Humana Inc (HUM) Stock Worth a Buy Monday?

Related Companies